AKT1 and metabolic dysfunction-associated steatotic liver disease: Subsequently, AKT and mTOR expression levels were significantly higher in mice maintained on the HFD over the 48-week period, therefore AKT/mTOR pathway contributed to the progressive NAFLD development (Figure 4A,B).